The heart in progressive systemic sclerosis (scleroderma): Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
(3 intermediate revisions by 2 users not shown)
Line 8: Line 8:
   OMIM          = 181750 |
   OMIM          = 181750 |
   MedlinePlus    = 000429 |
   MedlinePlus    = 000429 |
  eMedicineSubj  = derm|
  eMedicineTopic = 677|
  eMedicine_mult = {{eMedicine2|ped|2197}} |
   DiseasesDB    = 12845 |
   DiseasesDB    = 12845 |
   MeshID        = D012595 |
   MeshID        = D012595 |
Line 16: Line 13:
{{SI}}
{{SI}}
{{CMG}}   
{{CMG}}   
'''Associate Editor-In-Chief:''' {{CZ}}
'''Assistant Editor-In-Chief:''' [[Brian Blank]]
==Overview==
Severe complications from Progressive Systemic Scleroderma ([[Scleroderma]]) can include:


'''Associate Editor-In-Chief:''' {{CZ}}
*Untreated [[high blood pressure]] that strains the heart
*enlargement of the heart, which leads to [[heart failure]]


{{Editor Join}}
*[[pericardial effusion]]


==Overview==
*[[arrhythmias]] (both atrial and ventricular)


Severe complications from Progressive Systemic Scleroderma ([[Scleroderma]]) can include:
*conduction system defects


*Untreated high blood pressure that strains the heart
*valvular abnormalities


*irregular heart rhythm
*[[myocardial ischaemia]]


*enlargement of the heart, which leads to heart failure.
*myocardial [[hypertrophy]]<ref name="pmid16606654">{{cite journal |author=Akram MR, Handler CE, Williams M, ''et al'' |title=Angiographically proven coronary artery disease in scleroderma |journal=Rheumatology (Oxford) |volume=45 |issue=11 |pages=1395–8 |year=2006 |month=November |pmid=16606654 |doi=10.1093/rheumatology/kel120|url=}}</ref>


It's generally thought cardiac disease is a major cause of death from scleroderma, or that it often contributes to death.  Conduction abnormalities, [[myocardial]] and [[pericardial disease]] disease may also be common.
It's generally thought cardiac disease is a major cause of death from scleroderma, or that it often contributes to death, though cardiac disease is only reported in about 10 percent of cases.  Conduction abnormalities, [[myocardial]] and [[pericardial disease]] disease may also be common.  Some have suggested a 'cardiac [[Raynaud's phenomenon]]' exists, but exactly how myocardial involvement develops in scleroderma is unclear.


An angiography-based study of 172 patients has suggested patients who may have obstructive epicardial disease associated with scleroderma should be treated the same as patients without scleroderma.<ref name="pmid16606654">{{cite journal |author=Akram MR, Handler CE, Williams M, ''et al'' |title=Angiographically proven coronary artery disease in scleroderma |journal=Rheumatology (Oxford) |volume=45 |issue=11 |pages=1395–8 |year=2006 |month=November |pmid=16606654 |doi=10.1093/rheumatology/kel120 |url=}}</ref>
An angiography-based study of 172 patients has suggested patients who may have obstructive epicardial disease associated with scleroderma should be treated the same as patients without scleroderma.<ref name="pmid16606654">{{cite journal |author=Akram MR, Handler CE, Williams M, ''et al'' |title=Angiographically proven coronary artery disease in scleroderma |journal=Rheumatology (Oxford) |volume=45 |issue=11 |pages=1395–8 |year=2006 |month=November |pmid=16606654 |doi=10.1093/rheumatology/kel120 |url=}}</ref>
Line 55: Line 58:


{{Circulatory system pathology}}
{{Circulatory system pathology}}
{{SIB}}
 


[[Category:Cardiology]]
[[Category:Cardiology]]

Latest revision as of 16:49, 20 August 2012

Template:DiseaseDisorder infobox

WikiDoc Resources for The heart in progressive systemic sclerosis (scleroderma)

Articles

Most recent articles on The heart in progressive systemic sclerosis (scleroderma)

Most cited articles on The heart in progressive systemic sclerosis (scleroderma)

Review articles on The heart in progressive systemic sclerosis (scleroderma)

Articles on The heart in progressive systemic sclerosis (scleroderma) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on The heart in progressive systemic sclerosis (scleroderma)

Images of The heart in progressive systemic sclerosis (scleroderma)

Photos of The heart in progressive systemic sclerosis (scleroderma)

Podcasts & MP3s on The heart in progressive systemic sclerosis (scleroderma)

Videos on The heart in progressive systemic sclerosis (scleroderma)

Evidence Based Medicine

Cochrane Collaboration on The heart in progressive systemic sclerosis (scleroderma)

Bandolier on The heart in progressive systemic sclerosis (scleroderma)

TRIP on The heart in progressive systemic sclerosis (scleroderma)

Clinical Trials

Ongoing Trials on The heart in progressive systemic sclerosis (scleroderma) at Clinical Trials.gov

Trial results on The heart in progressive systemic sclerosis (scleroderma)

Clinical Trials on The heart in progressive systemic sclerosis (scleroderma) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on The heart in progressive systemic sclerosis (scleroderma)

NICE Guidance on The heart in progressive systemic sclerosis (scleroderma)

NHS PRODIGY Guidance

FDA on The heart in progressive systemic sclerosis (scleroderma)

CDC on The heart in progressive systemic sclerosis (scleroderma)

Books

Books on The heart in progressive systemic sclerosis (scleroderma)

News

The heart in progressive systemic sclerosis (scleroderma) in the news

Be alerted to news on The heart in progressive systemic sclerosis (scleroderma)

News trends on The heart in progressive systemic sclerosis (scleroderma)

Commentary

Blogs on The heart in progressive systemic sclerosis (scleroderma)

Definitions

Definitions of The heart in progressive systemic sclerosis (scleroderma)

Patient Resources / Community

Patient resources on The heart in progressive systemic sclerosis (scleroderma)

Discussion groups on The heart in progressive systemic sclerosis (scleroderma)

Patient Handouts on The heart in progressive systemic sclerosis (scleroderma)

Directions to Hospitals Treating The heart in progressive systemic sclerosis (scleroderma)

Risk calculators and risk factors for The heart in progressive systemic sclerosis (scleroderma)

Healthcare Provider Resources

Symptoms of The heart in progressive systemic sclerosis (scleroderma)

Causes & Risk Factors for The heart in progressive systemic sclerosis (scleroderma)

Diagnostic studies for The heart in progressive systemic sclerosis (scleroderma)

Treatment of The heart in progressive systemic sclerosis (scleroderma)

Continuing Medical Education (CME)

CME Programs on The heart in progressive systemic sclerosis (scleroderma)

International

The heart in progressive systemic sclerosis (scleroderma) en Espanol

The heart in progressive systemic sclerosis (scleroderma) en Francais

Business

The heart in progressive systemic sclerosis (scleroderma) in the Marketplace

Patents on The heart in progressive systemic sclerosis (scleroderma)

Experimental / Informatics

List of terms related to The heart in progressive systemic sclerosis (scleroderma)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Assistant Editor-In-Chief: Brian Blank

Overview

Severe complications from Progressive Systemic Scleroderma (Scleroderma) can include:

  • conduction system defects
  • valvular abnormalities

It's generally thought cardiac disease is a major cause of death from scleroderma, or that it often contributes to death, though cardiac disease is only reported in about 10 percent of cases. Conduction abnormalities, myocardial and pericardial disease disease may also be common. Some have suggested a 'cardiac Raynaud's phenomenon' exists, but exactly how myocardial involvement develops in scleroderma is unclear.

An angiography-based study of 172 patients has suggested patients who may have obstructive epicardial disease associated with scleroderma should be treated the same as patients without scleroderma.[1]

Pathology

Images courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

This is a gross photograph of the heart from a patient with scleroderma. There is thickening of the left ventricular wall and some thickening of the right ventricle as well.


Scleroderma: Right ventricular hypertrophy due to pulmonary fibrosis in Scleroderma


Scleroderma: Right ventricular hypertrophy due to pulmonary fibrosis in Scleroderma


Scleroderma: Right ventricular hypertrophy due to pulmonary fibrosis in Scleroderma


References

  1. 1.0 1.1 Akram MR, Handler CE, Williams M; et al. (2006). "Angiographically proven coronary artery disease in scleroderma". Rheumatology (Oxford). 45 (11): 1395–8. doi:10.1093/rheumatology/kel120. PMID 16606654. Unknown parameter |month= ignored (help)



Template:WikiDoc Sources